4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-016667
Chief Strategy Officer sold 10,348 shares at $9.04 ($93,546)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nayak Sanjay · Chief Strategy Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-12 | Sale : show line 1 in the form 10b5-1 | −10,348 | $9.04 | $93,546 | 332,412 | D |
| Open-market sales · 10,348 sh · avg $9.04 · $93,546 | ||||||
Loading xslF345X05/tm266494-3_4seq1.xml…